IMR Press / EJGO / Volume 28 / Issue 6 / pii/2007211

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Survival rate and prognostic factors for patients who underwent surgical procedures for invasive carcinoma of the vulva in Serbia

Show Less
1 Institute of Gynecology and Obstetrics, Clinical Centre of Serbia, Belgrade, Serbia
Eur. J. Gynaecol. Oncol. 2007, 28(6), 477–479;
Published: 10 December 2007

Objectives: To determine five-year survival rate and prognostic factors for patients who underwent radical surgery for carcinoma of the vulva. Material and Method: 94 women were operated on from 1989 to 1996 at the Clinical Centre of Serbia. Results: Five­year survival was 78.56% for Stage I, 73.5% for Stage II, for Stage III - 14.28%, and for Stage IV - 7.14%. Five-year survival rate for tumor size between 2 cm and 5 cm was 57.14%, and for tumors larger than 5 cm, 28.57%. Five-year survival rate was 64.28% if no lymph nodes were involved, 21.43% if there were unilateral metastatic lymph nodes and 14.28% if bilateral lymph nodes had metastatic disease. Histologic grades of the tumor showed that for grade 1, five-year survival was 64.28%, for grade 2, 35.71 % and there were no survivors five years after surgery among patients with grade 3 tumor. Conclusion: FIGO stage, size of tumor, lymph node involvement and grade of tumor are significant prognostic factors for survival of patients after surgery.

Carcinoma of the vulva
Prognostic factors
Five-year survival rate
Back to top